We are happy to welcome in our network Rheacell, focusing on patients suffering from severe immune and inflammation-driven diseases with high unmet medical need.
REHACELL is a leading clinical stage biopharmaceutical stem cell company based in Heidelberg, Germany. Founded in 2012, RHEACELL’s declared goal is to help patients, that would have no other therapy options. RHEACELL fights rare diseases!
Based on the mode of action and relevant potency assays, RHEACELL has a broad pipeline to further broaden its clinical development and market access into different rare and orphan diseases.
We are looking forward to see your active participation in the network!
You can find here more information about RHEACELL.